Polygenic Score (PGS) ID: PGS000036

Predicted Trait
Reported Trait Type 2 diabetes
Mapped Trait(s) type 2 diabetes mellitus (MONDO_0005148)
Released in PGS Catalog: Oct. 14, 2019
Download Score FTP directory
Terms and Licenses
PGS obtained from the Catalog should be cited appropriately, and used in accordance with any licensing restrictions set by the authors. See EBI Terms of Use (https://www.ebi.ac.uk/about/terms-of-use/) for additional details.

Score Details

Score Construction
PGS Name gePS_T2D
Development Method
Name Pruning and Thresholding (P+T)
Parameters P < 0.1; r2 < 0.6
Variants
Original Genome Build GRCh37
Number of Variants 171,249
Effect Weight Type NR
PGS Source
PGS Catalog Publication (PGP) ID PGP000023
Citation (link to publication) Mahajan A et al. Nat Genet (2018)
Ancestry Distribution
Source of Variant
Associations (GWAS)
Multi-ancestry (including European): 100%
  • European
  • African
  • East Asian
  • Hispanic or Latin American
  • South Asian
455,313 individuals (100%)
Score Development/Training
European: 100%
117,946 individuals (100%)
PGS Evaluation
European: 40%
Not Reported: 20%
African: 20%
Hispanic or Latin American: 20%
5 Sample Sets

Development Samples

Source of Variant Associations (GWAS)
Study Identifiers Sample Numbers Sample Ancestry Cohort(s)
Europe PMC: 29632382
[
  • 55,005 cases
  • , 400,308 controls
]
 European, African American or Afro-Caribbean, East Asian, Hispanic or Latin American, South Asian NR
Score Development/Training
Study Identifiers Sample Numbers Sample Ancestry Cohort(s) Phenotype Definitions & Methods Age of Study Participants Participant Follow-up Time Additional Ancestry Description Additional Sample/Cohort Information
Europe PMC: 31322649
[
  • 5,639 cases
  • , 112,307 controls
]
 European UKB Prevalent T2D status was defined using self-reported medical history and medication — — — —

Performance Metrics

Disclaimer: The performance metrics are displayed as reported by the source studies. It is important to note that metrics are not necessarily comparable with each other. For example, metrics depend on the sample characteristics (described by the PGS Catalog Sample Set [PSS] ID), phenotyping, and statistical modelling. Please refer to the source publication for additional guidance on performance.

PGS Performance
Metric ID (PPM) 		PGS Sample Set ID
(PSS) 		Performance Source Trait PGS Effect Sizes
(per SD change) 		Classification Metrics Other Metrics Covariates Included in the Model PGS Performance:
Other Relevant Information
PPM000080 PSS000054|
European Ancestry|
324,870 individuals
 PGP000024 |
Udler MS et al. Endocr Rev (2019)
|Ext.		 Reported Trait: Type 2 diabetes — AUROC: 0.66 — genotyping array, first 6 PCs of ancestry —
PPM000081 PSS000054|
European Ancestry|
324,870 individuals
 PGP000024 |
Udler MS et al. Endocr Rev (2019)
|Ext.		 Reported Trait: Type 2 diabetes — AUROC: 0.73 — age, sex, genotyping array, first 6 PCs of ancestry —
PPM014802 PSS009895|
European Ancestry|
1,168 individuals
 PGP000338 |
Oram RA et al. Diabetes Care (2022)
|Ext.		 Reported Trait: Diabetes autoantibody positive insulin sensitive — AUROC: 0.661 [0.606, 0.716] — — —
PPM014804 PSS009893|
African Ancestry|
366 individuals
 PGP000338 |
Oram RA et al. Diabetes Care (2022)
|Ext.		 Reported Trait: Diabetes autoantibody positive insulin sensitive — AUROC: 0.574 [0.506, 0.643] — — —
PPM014806 PSS009894|
Hispanic or Latin American Ancestry|
412 individuals
 PGP000338 |
Oram RA et al. Diabetes Care (2022)
|Ext.		 Reported Trait: Diabetes autoantibody positive insulin sensitive — AUROC: 0.722 [0.667, 0.778] — — —
PPM014808 PSS009896|
Ancestry Not Reported|
99 individuals
 PGP000338 |
Oram RA et al. Diabetes Care (2022)
|Ext.		 Reported Trait: Diabetes autoantibody positive insulin sensitive — AUROC: 0.677 [0.532, 0.822] — — —

Evaluated Samples

PGS Sample Set ID
(PSS) 		Phenotype Definitions and Methods Participant Follow-up Time Sample Numbers Age of Study Participants Sample Ancestry Additional Ancestry Description Cohort(s) Additional Sample/Cohort Information
PSS000054 Prevalent T2D status was defined using self-reported medical history and medication —
[
  • 13,480 cases
  • , 311,390 controls
]
 — European — UKB —
PSS009893 — — 366 individuals — African American or Afro-Caribbean — SEARCH —
PSS009894 — — 412 individuals — Hispanic or Latin American — SEARCH —
PSS009895 — — 1,168 individuals — European — SEARCH —
PSS009896 — — 99 individuals — Not reported — SEARCH —